Enzymit
PrivateLast Round
Series A
Sep 25, 2024
Total Funding Raised
$15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Enzymit is a biotechnology company that develops a cell-free bioproduction platform using AI-driven computational enzyme design to create novel enzymes for sustainable manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enzymit Comparables
Compare Enzymit with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnginZyme | 85% | |
| Debut | 83% | |
| Zymvol Biomodeling | 82% |
Enzymit Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 25, 2024 | ||||
| Seed | Apr 6, 2022 | ||||
| Pre Seed | Jul 1, 2020 |
Key People
Founding team and executive leadership
Enzymit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series A |
| Grove Ventures | Series A |
| First Star Ventures | Series A, Seed |
| NextLeap Ventures | Seed |
| Sapir Venture Partners | Series A, Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 95% MoM.
- Nov 10, 2025
First company to produce Hyaluronic Acid via enzymatic, cell-free process.
Enzymit Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Enzymit's valuation, stock price, and market status.
Is Enzymit a public or private company?
Enzymit is a private company.
What is the current stock price of Enzymit?
Enzymit is a private company with no public stock price. No recent secondary market data is available.
How much is Enzymit worth (valuation)?
Valuation information for Enzymit is not publicly available.
Can I buy Enzymit stock?
Enzymit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Enzymit's last funding round?
Enzymit's most recent funding round was Series A on September 25, 2024.
Who are the main investors in Enzymit?
Key investors in Enzymit include Khosla Ventures, Grove Ventures, First Star Ventures.
Will Enzymit IPO soon?
No public IPO plans have been announced for Enzymit.
How can I track Enzymit secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Enzymit's secondary market activity and sign up for updates.